Myriad Genetics (MYGN) announced the addition of Glenn Farrell as SVP and chief marketing officer, or CMO. Farrell is responsible for leading the brand, digital marketing, and communications strategy for the enterprise. He has more than 25 years of experience leading brand strategy and successful go-to-market programs in healthcare, life sciences and technology. He most recently served as the CMO and founding team member at Sema4 Holdings Corp (SMFR).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MYGN:
- Myriad Genetics Hires Five Senior Leaders to Advance Commercial Growth Plans
- Here’s why Natera is jumping in afternoon trading
- ACMG publishes new guideline recommending NIPS for all pregnant individuals
- ACMG updated recommendations a positive for Natera, Myriad, says Stephens
- Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction than Standard-of-Care Risk Model